Stockreport

Incyte reports full results from late-stage ruxolitinib studies in vitiligo [Seeking Alpha]

Incyte Corporation  (INCY) 
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
PDF Incyte reports full results from late-stage ruxolitinib studies in vitiligo [Read more]